Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
Public ClinicalTrials.gov record NCT00903175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter Phase II Study to Compare the Efficacy and Safety of RAD001 as First-line Followed by Second-line Sunitinib Versus Sunitinib as First-line Followed by Second-line RAD001 in the Treatment of Patients With Metastatic Renal Cell Carcinoma.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study assessed the efficacy and safety of first-line RAD001 followed by second-line sunitinib versus the opposite sequence: first-line sunitinib followed by second-line RAD001 for the treatment of patients with MRCC.
Study identification
- NCT ID
- NCT00903175
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 471 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2009 (Type not available)
- Primary completion
- May 2015 (Actual)
- Completion
- May 2015 (Actual)
- Last update posted
- Nov 8, 2016
2009 – 2015
United States locations
- U.S. sites
- 35
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham/ Kirklin Clinic Comprehensive CancerCenter (1) | Birmingham | Alabama | 35294-0006 | — |
| University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst. | Mobile | Alabama | 36688 | — |
| Highlands Oncology Group HighlandsOncGrp-Bentonville(2) | Fayetteville | Arkansas | 72703 | — |
| University of California San Diego - Moores Cancer Center Dept of Moores Cancer Ctr (5) | La Jolla | California | 92093-0658 | — |
| University of California at Los Angeles Dept. of UCLA (3) | Los Angeles | California | 90095 | — |
| University of Colorado Dept. of Anschutz Cancer (2) | Aurora | Colorado | 80045 | — |
| Norwalk Hospital Norwlak SC | Norwalk | Connecticut | 06856 | — |
| Georgetown University/Lombardi Cancer Center Dept.of Lombardi Cancer Ctr (2 | Washington D.C. | District of Columbia | 20007-2197 | — |
| Lynn Cancer Institute | Boca Raton | Florida | 33486 | — |
| University of Miami SC | Miami | Florida | 33136 | — |
| MD Anderson Cancer Center - Orlando Dept.ofMDACC-Orlando | Orlando | Florida | 32806 | — |
| University Cancer & Blood Center, LLC Dept of NE GCC (2) | Athens | Georgia | 30607 | — |
| Georgia Health Sciences University Dept. of MCG | Augusta | Georgia | 30912 | — |
| Summit Cancer Care | Savannah | Georgia | 31405 | — |
| NorthwesternUniv.Med.School/Robert H. Lurie Comp.Cancer Ctr Dept.ofNorthwesternMemHospital | Chicago | Illinois | 60611 | — |
| Loyola University Medical Center /Cardinal Bernardin Cancer Cardinal Bernardin Cancer (3) | Maywood | Illinois | 60153 | — |
| Crescent City Research Consortium, LLC SC | Metairie | Louisiana | 70006 | — |
| VA Maryland Health Care Dept.of GreenbaumCancerCent(7) | Baltimore | Maryland | 21201 | — |
| Weinberg Cancer Institute at Franklin Square Hospital | Baltimore | Maryland | 21237-3998 | — |
| Billings Clinic Dept of Billings Clinic(2) | Billings | Montana | 59107 | — |
| Hackensack University Medical Center DeptofHackensackUniv.MedCtr. | Hackensack | New Jersey | 07601 | — |
| Cooper Cancer Center | Voorhees Township | New Jersey | 08043 | — |
| Clinical Research Alliance | Lake Success | New York | 11042 | — |
| Memorial Sloan Kettering Cancer Center Dept. of MSKCC | New York | New York | 10065 | — |
| SUNY - Upstate Medical University Div. of Hematology-Oncology | Syracuse | New York | 13210 | — |
| University of North Carolina Dept. of LinbergerCancerCtr(3) | Chapel Hill | North Carolina | 27599-7295 | — |
| Levine Cancer Institute Oncology | Charlotte | North Carolina | 28203 | — |
| Duke University Medical Center Duke | Durham | North Carolina | 27710 | — |
| University of Oklahoma Health Sciences Center Dept of OHSC | Oklahoma City | Oklahoma | 73104 | — |
| St. Luke's Hospital and Health Network St Luke's Hospital (2) | Bethlehem | Pennsylvania | 18015 | — |
| The West Clinic Dept. of the West Clinic | Memphis | Tennessee | 38120 | — |
| The Center for Cancer and Blood Disorders Dept. of The Ctr for C & BD(2) | Fort Worth | Texas | 76104 | — |
| East Texas Medical Center Cancer Institute | Tyler | Texas | 75701 | — |
| Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) | Salt Lake City | Utah | 84106 | — |
| Aurora Advanced Healthcare SC | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 49 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00903175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 8, 2016 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00903175 live on ClinicalTrials.gov.